News

Ideas That Generate Results

The increasing prevalence of diabetic patients across the world is likely to fuel the growth in global insulin market. Moreover, innovative delivery devices substantially drive the growth in this market. Such high technology delivery devices provide efficient monitoring and detection of the patients. Even the key players catering to insulin market have gradually moved to modern insulins thereby eating up the market share. Moreover, government has acknowledged the treatment of diabetes through allocation of funds thereby increasing usage of insulin across the globe.

Research Analysis & Highlights

Increasing prevalence of diabetes patient population will boost the growth of insulin market which may reach to approximately US$ 45 Billion by the end of 2018. According to RNCOS Research Report, "Global Insulin Market Outlook 2018", the growth is also attributed because of the innovation in insulin delivery devices.

The report takes into account the key aspects of the global insulin market and projects the market during 2013-2018. Our report prudently analyzed major players, their product portfolio, recent developments, diabetes prevalence across different geographies, current and future market size for global insulin market as well as geographical markets of India, China, US, Russia, etc. Our comprehensive research work also studies how patent expiry of block buster insulin products would create opportunities for biosimilars.

Overall, the report aims at providing reliable and complete information about the global insulin market to clients and potential investors.

Some of the key findings of the report are:

            - US- Potential Insulin Market
            - Novo Nordisk leading the Insulin Market

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM681.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm